Inhibitors | Comment | Organism | Structure |
---|---|---|---|
(E)-2-[2-(4-(dimethylamino)phenyl)vinyl]benzoic acid | i.e. DS2CO, 2 mM, mechanism | Sus scrofa | |
(E)-3-[2-(4-(dimethylamino)phenyl)vinyl]benzoic acid | 2 mM, 80-90% inhibition, mechansim; i.e. DS3CO | Sus scrofa |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Sus scrofa | - |
- |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
liver | - |
Sus scrofa | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
imipramine + NADPH + O2 | - |
Sus scrofa | ? | - |
? | |
methimazole + NADPH + O2 | - |
Sus scrofa | N-methylmethimidazole-2-sulfinic acid + NADP+ + H2O | - |
? | |
tamoxifen + NADPH + O2 | - |
Sus scrofa | ? | - |
? | |
trifluoperazine + NADPH + O2 | - |
Sus scrofa | ? | - |
? |